Who invested in TTS Pharma?
TTS Pharma's investors include North West Fund.

United Kingdom · Series B startup
Funding summaryUpdated 26 Oct 2026
$21Mraised across 8 rounds since 2012, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
TTS Pharma filed 7 raises, $4.1M in all. Filings say how much was sold and to how many investors; they never name the investors.
TTS Pharma's investors include North West Fund.
TTS Pharma has raised $21M across 8 rounds since 2012.
TTS Pharma's most recent round, $2.4M, was in Sept 2025.
TTS Pharma's largest round on record is $13M (Series B), in May 2019.
TTS Pharma's first round on record, in Dec 2012, was backed by North West Fund.
TTS Pharma's latest named round is a Series B, in May 2019.
TTS Pharma is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.